Monovalent Nondegrading Molecular Glues: An Updated Overview of Emerging Mechanisms and Therapeutic Development
Linfeng Li, Jiajia Li, Li Yang, Jun Zhou, Yuying Ma · 2026
Read Monovalent Nondegrading Molecular Glues: An Updated Overview of Emerging Mechanisms and Therapeutic Development by Linfeng Li, Jiajia Li, Li Yang, Jun Zhou, Yuying Ma (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13610670.txt.
Description
Linfeng Li and co-authors review a class of small drug-like molecules that glue proteins together without destroying them, in a 2026 paper. Most drugs work by blocking a protein's active site. These glues work another way: they coax two cell parts into a new partnership, which shifts what the joined complex does or where it sits in the cell.
Once thought to be rare quirks of natural products, such glues are now built on purpose, and several have reached clinical trials. The review tours their use against cancer networks, immune activity, metabolism, brain cell traffic, and pathogen assemblies. In each area it weighs the target's value, how the glue works, and what blocks progress. The class widens the set of proteins that drugs can reach, including many long called undruggable.
Catalog record
| CREATOR | Linfeng Li, Jiajia Li, Li Yang, Jun Zhou, Yuying Ma |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 73 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |